Davide Campari-Milano (BIT:CPR) As Weak Earnings Test The Case For Undervalued Shares
Why Davide Campari-Milano Stock Is Back In Focus After Earnings
Davide Campari-Milano (BIT:CPR) is drawing fresh investor attention after reporting half year 2026 earnings that showed slightly lower sales and a sharper decline in net income versus the prior year period.
See our latest analysis for Davide Campari-Milano.
Despite the weaker half year 2026 results, Davide Campari-Milano’s recent momentum has been positive, with a 30 day share price return of 4.31% and a year to date share price return of 7.11%, even as the 1 year total shareholder return is down 9.40%.
If this earnings move has you reassessing your watchlist, it could be a good moment to broaden your search with our 107 top founder-led companies
Davide Campari-Milano still appears to be a solid global spirits business, even after the recent earnings setback. Given the mixed share price track record, the key issue now is whether the current valuation fairly reflects that quality.
Most Popular Narrative: 16.5% Undervalued
With Davide Campari-Milano last closing at €5.90 against a narrative fair value of €7.06, the current pricing sits below what the most followed valuation framework suggests. That gap rests on specific forecasts for growth, margins and the earnings multiple that investors are assumed to pay in future.
Analysts are assuming Davide Campari-Milano's revenue will grow by 3.3% annually over the next 3 years. Analysts assume that profit margins will increase from 11.3% today to 13.9% in 3 years time.
So what justifies a higher fair value for Davide Campari-Milano than today’s price suggests? The core of this narrative is steadier top line progress, higher margins and a richer P/E multiple than the sector usually commands. Curious which earnings and valuation bridge links those assumptions together into €7.06.
Result: Fair Value of €7.06 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this Davide Campari-Milano narrative could be challenged if tariffs bite harder into earnings, or if reliance on Aperol and Campari leaves growth more exposed.
Find out about the key risks to this Davide Campari-Milano narrative.
Another View On Davide Campari-Milano’s Valuation
There is a clear story of upside in the fair value of €7.06. However, on a simple P/E basis Davide Campari-Milano looks expensive at 26.3x compared with a fair ratio of 19x, the European beverage industry at 18.2x and peers at 38.6x. That gap raises a practical question for you about how much valuation risk is acceptable if earnings do not track the narrative.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With mixed signals around Davide Campari-Milano’s earnings, valuation and narrative, it makes sense to look through the underlying data yourself and move quickly while sentiment is still forming. To weigh up both the concerns and the potential upside, take a closer look at the 4 key rewards and 2 important warning signs
Looking For More Investment Ideas Beyond Davide Campari-Milano?
If you are serious about building a stronger portfolio after reviewing Davide Campari-Milano, do not stop here. Fresh ideas often appear where you least expect.
- Spot potential turnarounds early by scanning 226 elite penny stocks with strong financials that already back their stories with stronger balance sheets and healthier financial profiles.
- Zero in on quality at a reasonable price by using the 252 high quality undervalued stocks that filters for companies with solid cash flows and supportive fundamentals.
- Prioritise resilience by checking the solid balance sheet and fundamentals stocks screener (422 results) where companies pair financial strength with sound underlying business metrics.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com